The global medical technology (MedTech) landscape continues to evolve, and Ireland has been at the forefront of this transformation. The country has emerged as a leader in the sector, attracting multinational companies and driving cutting-edge advancements which are advancing patient care. With approximately 450 MedTech companies operating across the country, the sector employs over 45,000 people, making Ireland the largest employer of MedTech professionals in Europe per capita. This success story is the result of a unique ecosystem which has made Ireland a destination of choice for MedTech companies. As we look ahead, IDA Ireland has identified health as one of the four strategic growth drivers for investment for the rest of this decade. From the development of smart medical technology to advanced manufacturing, the agency’s latest five-year strategy seeks to capitalise on opportunities within the MedTech sector. In an era of rapid change, driven by emerging technologies and increased global competition, the question we must ask ourselves is: How we do we unlock the opportunities that lie ahead and enhance Ireland’s position as a MedTech hub into the future? The answer lies in a laser focus on research, development and innovation. However, to ensure that innovation can flourish, we must focus on developing and embracing new technologies, reinforcing ties with academia and healthcare institutions, and investing in the upskilling and reskilling of our workforce. Ireland’s success in MedTech stems from the presence of international and home-grown organisations that are deeply committed to research and development. Ultimately, the global MedTech industry is dedicated to saving lives and improving patient outcomes, particularly in the context of an aging global population. Achieving this requires an ongoing commitment to innovation. Companies must not only stay ahead of evolving patient needs but also integrate new technologies seamlessly. Stryker, which has been at the very heart of Ireland’s MedTech landscape for over 25 years, has a track record of staying one step ahead of change, developing disruptive technologies and advancing innovation to drive meaningful change for patients and healthcare professionals. We are particularly proud of the progress we have made in Ireland in the field of 3D printing. Our AMagine Institute in Carrigtwohill is home to one of the world’s largest additive manufacturing facilities. The institute is pioneering the transformation of the manufacturing process, enabling the creation of custom devices tailored to individual patients. As MedTech companies embrace new technologies and move towards alternative ways of manufacturing like 3D printing, the realms of possibility will continue to expand, and innovation will continue to flourish. The success of our 3D technology is just one example of how Ireland’s MedTech sector can continue to lead by developing cutting-edge technologies. Advancements in AI, robotics and digital twin technology are some of the other technologies that the workforce within the MedTech sector will need to continue to embrace to maintain Ireland’s competitiveness. The MedTech industry cannot thrive in isolation. It is essential to broaden the culture of collaboration that has emerged in recent years and deepen the ties between industry, our world class research community, supply chain partners and clinical colleagues. As highlighted in Ireland’s Industry 4.0 Strategy, the government recognises the need to foster collaboration both inside and outside the MedTech sector. To maintain Ireland’s position at the forefront of MedTech, a strong collaborative culture should be a top priority. Deepening collaboration between industry and academia is also crucial to protecting and enhancing the pipeline of skilled talent that fuels innovation. With the MedTech workforce in Ireland projected to expand to more than 56,000 people by 2028, it is important to foster the development of highly skilled professionals long into the future. Stryker’s impact extends beyond our own business—we are deeply integrated with Ireland’s academic and healthcare institutions, particularly in the South and Midwest, which provide a stream of research, talent and clinical insights and fuel our technological advancements. Through Stryker’s partnerships, we are not only strengthening our portfolio but also contributing to Ireland’s position as a hub for medical technology. We work closely with Cork University Hospital (CUH) and University College Cork (UCC) on research into brain tumors to identify margins between healthy and cancerous tissue at the Instruments Innovation Centre, while the Neurovascular Innovation Hub in Cork designs and develops medical devices to treat stroke patients around the globe. Innovation and transformation are as much about people as they are about technology. That’s why the development of new technologies must be supported by a highly skilled and diverse workforce equipped to meet the future demands of the sector. The pathway from Ireland’s third level institutions to the MedTech industry must be strong, ensuring that students have the practical skills necessary to succeed. In addition, as the pace of technological change accelerates, upskilling and reskilling will become more critical in meeting the future needs of the sector. At Stryker, we recognise the importance of our people, and we invest in our people and their skills. Through programmes such as graduate schemes, apprenticeships and educational assistance initiatives, Stryker is ensuring that our employees are prepared for the challenges of advanced manufacturing and disruptive technologies. Moreover, broader national investment in training and upskilling is necessary to maintain Ireland’s competitive edge. It is not enough for Ireland’s workforce to simply adopt the latest technologies; we must play a central role in shaping and developing them.

Strengthening Ireland's MedTech Leadership Through Technology, Talent and Innovation - Irish Tech News

Ireland has emerged as a leader in the global MedTech sector, with approximately 450 companies employing over 45,000 people. The country's success is attributed to a unique ecosystem that has made it a preferred destination for MedTech companies. IDA Ireland has identified health as one of the four strategic growth drivers for investment, aiming to capitalize on opportunities within the MedTech sector. Stryker, a key player in Ireland's MedTech landscape, has been instrumental in driving innovation, particularly in 3D printing, and has partnerships with Cork University Hospital (CUH) and University College Cork (UCC) to advance medical technology.